Title of article
Rasagiline as an adjunct to levodopa in patients with Parkinsonʹs disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial
Author/Authors
O Rascol، نويسنده , , D.J. Brooks، نويسنده , , E Melamed، نويسنده , , W Oertel، نويسنده , , W Poewe، نويسنده , , F Stocchi، نويسنده , , E Tolosa ، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2005
Pages
8
From page
947
To page
954
Abstract
Background
Rasagiline mesylate is a novel drug for Parkinsonʹs disease with selective, irreversible monoamine oxidase B (MAO-B) inhibitor activity, and is effective as monotherapy in early disease. This study investigated rasagiline efficacy and safety in
Journal title
The Lancet
Serial Year
2005
Journal title
The Lancet
Record number
587812
Link To Document